FDA Approves Abbott’s Xience Prime Coronary Stent

US based pharmaceutical company Abbott Labs has revealed that its everolimus-eluting coronary stent has been approved by the Food and Drug Administration

US based pharmaceutical company Abbott Labs has revealed that its everolimus-eluting coronary stent has been approved by the Food and Drug Administration for the treatment of coronary artery disease.

Abbott said that the stent, known as Xience Prime, is similar to its predecessor Xience V as it uses the same drug and biocompatible polymer but the company added that Xience Prime offers thinner struts which help it to maintain radial strength and thus offer better delivery.

Heart Attack - Overview
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.

Confirming the approval of the stent, the FDA said that its decision was based on the SPIRIT PRIME trial which tested the effectiveness of the stent in 500 patients with coronary artery disease.

The FDA revealed that the stent showed lower rates of target lesion failure and stent thrombosis at the end of one year.

Source-Medindia

Olive Oil and Its Benefits - Heart-Weight Loss-Osteoporosis-Skin-Tips to Use
The anti-inflammatory and anti-oxidant properties are responsible for the health benefits of olive oil.

An Active Heart
The heart pumps blood constantly providing the power to sustain life.

Animation of heart attack symptoms
Heart attack can cause symptoms such as Chest pain or discomfort, Shortness of breath and pain in neck, back, arm, or shoulder and is due to blockage of blood supply to the heart muscles